Fairvalue-Calculator Fairvalue-Calculator
EN DE

Seoulin Bioscience Co (038070) Fair Value & Analysis

Healthcare · KR · Market cap 45.7B KRW

Price4,460 KRW
Fair Value1,824 KRW
Upside-59.1%
Quality93/100
Evidence: High Range 1,368 KRW – 2,280 KRW

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Seoulin Bioscience Co (038070) currently trades at 4,460 KRW, while our model-based Fair Value estimate is 1,824 KRW — implying the stock looks roughly 59.1% overvalued today. We read business quality at 93/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Seoulin Bioscience Co.,Ltd., a bio healthcare company, provides solutions in life sciences and healthcare primarily in South Korea. The company offers solutions for bio research and production; ecoTree, a SLB-120 instrument which produces slightly acidic electrolyzed water for used in food industry, living, and laboratory; plasma-based medical esthetics; miQ for the diagnosis of dementia; and functional cosmetics based on natural fermentation. Seoulin Bioscience Co.,Ltd. was founded in 1984 and is headquartered in Seongnam-si, South Korea.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -84% Regeneron Pharmaceuticals, Inc (REGN) +109% UCB SA (UCB) -23% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) +9% Alnylam Pharmaceuticals, Inc (ALNY) -64%

Frequently asked questions

Is Seoulin Bioscience Co (038070) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 1,824 KRW versus a price of 4,460 KRW — about −59% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 038070?
Our 21-model fair value for Seoulin Bioscience Co is 1,824 KRW (as of Jun 24, 2026), built from audited fundamentals. The current price is 4,460 KRW.
What is the quality score of 038070?
Seoulin Bioscience Co has a Quality Score of 93/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.